Planned scientific outputs
ECDC is committed to maintaining transparency and to this end, publishes a list of scientific outputs in planning. The list is updated weekly and spans a 12-month rolling period, encompassing both the preceding three months and the forthcoming nine months.
The list is not exhaustive and may be subject to change. Operational factors such as shifting priorities, resource allocation, and changes in stakeholder requests can influence the continuation or discontinuation of planned outputs. This list does not include outputs related to assessments, which are typically produced in response to immediate risks or unexpected events.
For any inquiries or feedback, reach out at ecdc [dot] info
ecdc [dot] europa [dot] eu (ecdc[dot]info[at]ecdc[dot]europa[dot]eu).
72 results found Export 72 results to CSV
The "Category" and "Status" values in the table below are explained in more detail here.
Evidence brief on the cost of testing of HIV, TB, viral hepatitis and STIs
Evidence brief: HIV and STIs among sex workers in EU/EEA
External quality assessment scheme for Haemophilus influenzae, 2026
External quality assessment scheme for Neisseria meningitidis , 2026
External quality assessment scheme for Streptococcus pneumoniae, 2026
External quality assurance scheme for antimicrobial susceptibility testing of macrolide-resistant Bordetella pertussis, 2025
Fifth Joint inter-agency report on integrated analysis of antimicrobial consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the European Union (JIACRA V 2022-2024)
Gonococcal antimicrobial susceptibility surveillance in the European Union/European Economic Area - 2024 data
Guidelines for respiratory virus surveillance
Handbook on simulation exercises in EU public health settings (update)